10-K Filing

HealthLynked Corp CIK: 1680139 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001213900-23-025432`
Period End Date	20221231
Filing Date	20230331
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	f10k2022_healthlynk_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 91 Income Statement 67 Cash Flow Statement 111 Stockholders Equity 28

Balance Sheet 91 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashEquivalentsAtCarryingValue`	$3.29M	USD	Point-in-time
Cash	`CashEquivalentsAtCarryingValue`	$61.89K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $-0- and $13,972 as of December 31, 2022 and 2021, respectively	`AccountsReceivableNetCurrent`	$72.28K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $-0- and $13,972 as of December 31, 2022 and 2021, respectively	`AccountsReceivableNetCurrent`	$86.29K	USD	Point-in-time
Inventory	`InventoryNet`	$192.83K	USD	Point-in-time
Inventory	`InventoryNet`	$134.93K	USD	Point-in-time
Contract assets	`ContractWithCustomerAssetGrossCurrent`	-	USD	Point-in-time
Contract assets	`ContractWithCustomerAssetGrossCurrent`	$269.74K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$92.94K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$137.63K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Current assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$1.45M	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$397.19K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$283.51K	USD	Point-in-time
Current assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	-	USD	Point-in-time
Net of unamortized original issue discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	$104.49K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$3.65M	USD	Point-in-time
Net of unamortized original issue discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	-	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$2.14M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $397,194 and $283,512 as of December 31, 2022 and 2021, respectively	`PropertyPlantAndEquipmentNet`	$350.48K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $397,194 and $283,512 as of December 31, 2022 and 2021, respectively	`PropertyPlantAndEquipmentNet`	$413.12K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $1,589,217 and $873,417 as of December 31, 2022 and 2021, respectively	`FiniteLivedIntangibleAssetsNet`	$3.81M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Intangible assets, net of accumulated amortization of $1,589,217 and $873,417 as of December 31, 2022 and 2021, respectively	`FiniteLivedIntangibleAssetsNet`	$1.11M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	255.94M	shares	Point-in-time
Goodwill	`Goodwill`	$319.96K	USD	Point-in-time
Goodwill	`Goodwill`	$766.25K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	237.89M	shares	Point-in-time
Right of use lease assets	`OperatingLeaseRightOfUseAsset`	$526.73K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	255.94M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	237.89M	shares	Point-in-time
Right of use lease assets	`OperatingLeaseRightOfUseAsset`	$540.18K	USD	Point-in-time
Deferred equity compensation and deposits	`DeferredEquityCompensationAndDeposit`	$138.62K	USD	Point-in-time
Deferred equity compensation and deposits	`DeferredEquityCompensationAndDeposit`	$50.91K	USD	Point-in-time
Long term assets held for sale	`OtherLongTermInvestments`	$1.45M	USD	Point-in-time
Long term assets held for sale	`OtherLongTermInvestments`	-	USD	Point-in-time
Total Assets	`Assets`	$4.58M	USD	Point-in-time
Total Assets	`Assets`	$10.69M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.60M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$790.84K	USD	Point-in-time
Common stock issuable, par value (in Dollars per share)	`CommonStockParValue`	$0.00	USD	Point-in-time
Common stock issuable, par value (in Dollars per share)	`CommonStockParValue`	$0.00	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	719,366.00	shares	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	2.59M	shares	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$574.85K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$47.84K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$288.97K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$344.46K	USD	Point-in-time
Notes payable and other amounts due to related party, net of unamortized original issue discount of $104,490 and $-0- as of December 31, 2022 and 2021, respectively	`NotesPayableRelatedPartiesCurrentAndNoncurrent`	$300.60K	USD	Point-in-time
Notes payable and other amounts due to related party, net of unamortized original issue discount of $104,490 and $-0- as of December 31, 2022 and 2021, respectively	`NotesPayableRelatedPartiesCurrentAndNoncurrent`	$506.11K	USD	Point-in-time
Notes payable, current portion, net of unamortized original issue discount of $37,748 and $-0- as of December 31, 2022 and 2021, respectively	`NotesPayableCurrent`	$291.65K	USD	Point-in-time
Notes payable, current portion, net of unamortized original issue discount of $37,748 and $-0- as of December 31, 2022 and 2021, respectively	`NotesPayableCurrent`	-	USD	Point-in-time
Liability-classified equity instruments, current portion	`LiabilityclassifiedEquityInstrumentsCurrentPortion`	$30.00K	USD	Point-in-time
Liability-classified equity instruments, current portion	`LiabilityclassifiedEquityInstrumentsCurrentPortion`	$61.25K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$403.47K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$100.07K	USD	Point-in-time
Current liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$25.00K	USD	Point-in-time
Current liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$25.00K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.92M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$3.47M	USD	Point-in-time
Government notes payable, long term portion	`GovernmentAndVendorNotesPayableLongTermPortion`	$450.00K	USD	Point-in-time
Government notes payable, long term portion	`GovernmentAndVendorNotesPayableLongTermPortion`	$450.00K	USD	Point-in-time
Liability-classified equity instruments, long term portion	`LongTermDebtNoncurrent`	$45.00K	USD	Point-in-time
Liability-classified equity instruments, long term portion	`LongTermDebtNoncurrent`	$101.25K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$782.22K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$98.24K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$239.22K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$198.33K	USD	Point-in-time
Total Liabilities	`Liabilities`	$4.27M	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.49M	USD	Point-in-time
Commitments and contingencies (Note 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 255,940,389 and 237,893,473 shares issued and outstanding as of December 31, 2022 and 2021, respectively	`CommonStockValue`	$23.79K	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 255,940,389 and 237,893,473 shares issued and outstanding as of December 31, 2022 and 2021, respectively	`CommonStockValue`	$25.59K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and 2,750,000 shares issued and outstanding as of December 31, 2022 and 2021, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and 2,750,000 shares issued and outstanding as of December 31, 2022 and 2021, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 2,585,542 and 719,366 shares as of December 31, 2022 and 2021, respectively	`CommonStockIssuableValue`	$282.35K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 2,585,542 and 719,366 shares as of December 31, 2022 and 2021, respectively	`CommonStockIssuableValue`	$225.58K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$39.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$41.08M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-32.21M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-41.02M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$7.20M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$314.45K	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$1.35M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$4.58M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$10.69M	USD	Point-in-time

Income Statement 67 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$5.41M	USD	Annual
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$5.76M	USD	Annual
Subscription and event revenue	`SubscriptionConsultingAndEventRevenue`	$-20.84K	USD	Annual
Subscription and event revenue	`SubscriptionConsultingAndEventRevenue`	$-14.88K	USD	Annual
Product revenue	`ProductRevenue`	$429.95K	USD	Annual
Product revenue	`ProductRevenue`	$718.06K	USD	Annual
Total revenue	`Revenues`	$5.86M	USD	Annual
Total revenue	`Revenues`	$6.50M	USD	Annual
Practice salaries and benefits	`LaborAndRelatedExpense`	$3.34M	USD	Annual
Practice salaries and benefits	`LaborAndRelatedExpense`	$3.11M	USD	Annual
Other practice operating expenses	`OtherCostAndExpenseOperating`	$2.57M	USD	Annual
Other practice operating expenses	`OtherCostAndExpenseOperating`	$2.35M	USD	Annual
Cost of product revenue	`CostOfProductRevenue`	$463.16K	USD	Annual
Cost of product revenue	`CostOfProductRevenue`	$606.52K	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$4.58M	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$4.93M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$827.70K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$829.48K	USD	Annual
Impairment loss	`GoodwillImpairmentLoss`	$2.75M	USD	Annual
Total Operating Expenses and Costs	`OperatingExpenses`	$11.83M	USD	Annual
Total Operating Expenses and Costs	`OperatingExpenses`	$14.52M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-5.33M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-8.66M	USD	Annual
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.96M	USD	Annual
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-19.25K	USD	Annual
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	Annual
Financing cost	`FinancingInterestExpense`	-	USD	Annual
Financing cost	`FinancingInterestExpense`	$110.00K	USD	Annual
Amortization of original issue discounts on notes payable	`AmortizationOfOriginalIssueDiscountsOnNotesPayable`	$-55.28K	USD	Annual
Amortization of original issue discounts on notes payable	`AmortizationOfOriginalIssueDiscountsOnNotesPayable`	-	USD	Annual
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-373.66K	USD	Annual
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$780.00K	USD	Annual
Interest (expense) income	`NonoperatingIncomeExpense`	$-22.82K	USD	Annual
Interest (expense) income	`NonoperatingIncomeExpense`	$-19.14K	USD	Annual
Total other income (expenses)	`OtherOperatingIncomeExpenseNet`	$591.89K	USD	Annual
Total other income (expenses)	`OtherOperatingIncomeExpenseNet`	$-5.37M	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.07M	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.70M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-10.70M	USD	Annual
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-8.07M	USD	Annual
Income (loss) from operations of discontinued operations (Note 4)	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$-748.26K	USD	Annual
Income (loss) from operations of discontinued operations (Note 4)	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$287.66K	USD	Annual
Net loss	`NetIncomeLoss`	$-10.41M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.82M	USD	Annual
Deemed dividend - amortization of beneficial conversion feature	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$353.57K	USD	Annual
Deemed dividend - amortization of beneficial conversion feature	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$353.57K	USD	Annual
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.77M	USD	Annual
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-9.17M	USD	Annual
Basic (in Dollars per share)	`Netlosspersharetocommonshareholdersbasic`	$-0.03	USD	Annual
Basic (in Dollars per share)	`Netlosspersharetocommonshareholdersbasic`	$-0.05	USD	Annual
Fully diluted (in Dollars per share)	`Netlosspersharetocommonshareholdersdiluted`	$-0.05	USD	Annual
Fully diluted (in Dollars per share)	`Netlosspersharetocommonshareholdersdiluted`	$-0.03	USD	Annual
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.05	USD	Annual
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.04	USD	Annual
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.04	USD	Annual
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.05	USD	Annual
Basic (in Dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.04	USD	Annual
Basic (in Dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.05	USD	Annual
Fully diluted (in Dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.05	USD	Annual
Fully diluted (in Dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.04	USD	Annual
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	243.42M	shares	Annual
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	224.66M	shares	Annual
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	224.66M	shares	Annual
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	243.42M	shares	Annual

Cash Flow Statement 111 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-10.41M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.82M	USD	Annual
(Income) loss from discontinued operations	`IncomeLossFromDiscontinuedOperations`	$-748.26K	USD	Annual
(Income) loss from discontinued operations	`IncomeLossFromDiscontinuedOperations`	$287.66K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$827.70K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$829.48K	USD	Annual
Impairment loss	`AssetImpairmentCharges`	$2.75M	USD	Annual
Stock based compensation, including amortization of deferred equity compensation	`EmployeeBenefitsAndShareBasedCompensation`	$742.73K	USD	Annual
Stock based compensation, including amortization of deferred equity compensation	`EmployeeBenefitsAndShareBasedCompensation`	$439.76K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$55.28K	USD	Annual
Stock-based financing cost	`ShareBasedCompensation`	$100.00K	USD	Annual
Stock-based financing cost	`ShareBasedCompensation`	-	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.96M	USD	Annual
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-19.25K	USD	Annual
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	Annual
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$780.00K	USD	Annual
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$-373.66K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$14.63K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-36.51K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$44.63K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$39.73K	USD	Annual
Contract assets	`IncreaseDecreaseInContractAssets`	-	USD	Annual
Contract assets	`IncreaseDecreaseInContractAssets`	$269.74K	USD	Annual
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-51.53K	USD	Annual
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$48.06K	USD	Annual
Right of use lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$109.59K	USD	Annual
Right of use lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$351.72K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-138.72K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$701.61K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiability`	$114.25K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiability`	$350.57K	USD	Annual
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$527.01K	USD	Annual
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$6.28K	USD	Annual
Net cash used in continuing operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.67M	USD	Annual
Net cash used in continuing operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.02M	USD	Annual
Net cash (used in) generated by discontinued operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-689.07K	USD	Annual
Net cash (used in) generated by discontinued operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$249.42K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.36M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.77M	USD	Annual
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$313.80K	USD	Annual
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$207.38K	USD	Annual
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$322.11K	USD	Annual
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.56K	USD	Annual
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.25K	USD	Annual
Net cash used in continuing investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-341.36K	USD	Annual
Net cash used in continuing investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-544.75K	USD	Annual
Net cash used in discontinued investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	Annual
Net cash used in discontinued investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-341.36K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-544.75K	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$956.79K	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$6.95M	USD	Annual
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	-	USD	Annual
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	$350.20K	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	$943.30K	USD	Annual
Repayment of notes payable	`RepaymentsOfNotesPayable`	$222.07K	USD	Annual
Repayment of notes payable	`RepaymentsOfNotesPayable`	$51.11K	USD	Annual
Repurchase of treasury stock	`PaymentsForRepurchaseOfOtherEquity`	-	USD	Annual
Repurchase of treasury stock	`PaymentsForRepurchaseOfOtherEquity`	$7.70K	USD	Annual
Net cash provided by continuing financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$7.24M	USD	Annual
Net cash provided by continuing financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.68M	USD	Annual
Net cash provided by discontinued financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	Annual
Net cash provided by discontinued financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.68M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.24M	USD	Annual
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.23M	USD	Annual
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$3.13M	USD	Annual
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$61.89K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$162.18K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$61.89K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$162.18K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$232.00	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	$5.92K	USD	Annual
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	Annual
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	Annual
Fair value of shares issued as purchase price consideration	`FairValueOfSharesIssuedAsPurchasePriceConsideration`	$103.80K	USD	Annual
Fair value of shares issued as purchase price consideration	`FairValueOfSharesIssuedAsPurchasePriceConsideration`	-	USD	Annual
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$262.27K	USD	Annual
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$305.07K	USD	Annual
Net carrying value of equity liabilities (assets) written off	`NetCarryingValueOfEquityLiabilitiesassetsWrittenOff`	$428.86K	USD	Annual
Net carrying value of equity liabilities (assets) written off	`NetCarryingValueOfEquityLiabilitiesassetsWrittenOff`	-	USD	Annual
Recognition of operating lease: right of use asset and lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$284.90K	USD	Annual
Recognition of operating lease: right of use asset and lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	Annual
Proceeds from sale of common stock under Standby Equity Purchase Agreement applied to note payable balance	`ProceedsFromSaleOfCommonStockUnderStandbyEquityPurchaseAgreementAppliedToNote`	-	USD	Annual
Proceeds from sale of common stock under Standby Equity Purchase Agreement applied to note payable balance	`ProceedsFromSaleOfCommonStockUnderStandbyEquityPurchaseAgreementAppliedToNote`	$279.42K	USD	Annual
Fair value of warrants allocated to proceeds of debt	`FairValueOfWarrantsAllocatedToProceedsOfDebt`	$35.28K	USD	Annual
Fair value of warrants allocated to proceeds of debt	`FairValueOfWarrantsAllocatedToProceedsOfDebt`	-	USD	Annual
Debt discount and original issue discount allocated to proceeds of notes payable	`DebtDiscountAndOriginalIssueDiscountAllocatedToProceedsOfNotesPayable`	$153.63K	USD	Annual
Debt discount and original issue discount allocated to proceeds of notes payable	`DebtDiscountAndOriginalIssueDiscountAllocatedToProceedsOfNotesPayable`	-	USD	Annual
Forgiveness of government loans	`GainLossOnSalesOfLoansNet`	-	USD	Annual
Forgiveness of government loans	`GainLossOnSalesOfLoansNet`	$632.83K	USD	Annual
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	$43.24K	USD	Annual
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	-	USD	Point-in-time
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	$126.50K	USD	Point-in-time
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$4.06M	USD	Annual
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	-	USD	Annual
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	$3.07M	USD	Point-in-time
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	-	USD	Point-in-time
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	-	USD	Annual
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	$614.22K	USD	Annual
Contingent acquisition consideration payable in common stock	`ContingentAcquisitionConsiderationPayableInCommonStock`	$366.30K	USD	Annual
Contingent acquisition consideration payable in common stock	`ContingentAcquisitionConsiderationPayableInCommonStock`	-	USD	Annual
Fair value of liability-classified equity instruments issued	`StockIssued1`	$165.00K	USD	Annual
Fair value of liability-classified equity instruments issued	`StockIssued1`	-	USD	Annual

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$7.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$314.45K	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time
Sales of common stock	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$4.77M	USD	Annual
Sales of common stock pursuant to Standby Equity Purchase Agreement	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$451.20K	USD	Annual
Stock based financing fees	`StockIssuedDuringPeriodValueConversionOfUnits`	$100.00K	USD	Annual
Other sales of common stock	`StockIssuedDuringPeriodValueOther`	$570.35K	USD	Annual
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$214.65K	USD	Annual
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$2.18M	USD	Annual
Fair value of warrants allocated to proceeds of related party debt	`FairValueOfWarrantsAllocatedToProceedsOfRelatedPartyDebt`	$35.28K	USD	Annual
Shares issued in acquisition of AEU	`StockIssuedDuringPeriodValueAcquisitions`	$103.80K	USD	Annual
Contingent acquisition consideration issuable	`StockIssuedDuringPeriodValueIssuedForServices`	$366.30K	USD	Annual
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$4.06M	USD	Annual
Fair value of warrants issued in connection with conversion and retirement of convertible notes payable	`FairValueOfWarrantsIssuedAndModifiedInConnectionWithConversionAndRetirementOfConve`	$3.20M	USD	Annual
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$43.23K	USD	Annual
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$487.28K	USD	Annual
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$321.30K	USD	Annual
Shares and options issued to employees	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$129.71K	USD	Annual
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$200.97K	USD	Annual
Exercise of stock warrants	`Exerciseofwarrants`	$947.97K	USD	Annual
Exercise of stock options	`ExerciseOfStockOptionsValue`	$16.45K	USD	Annual
Exercise of stock options	`ExerciseOfStockOptionsValue`	-	USD	Annual
Repurchase of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$7.70K	USD	Annual
Net loss	`NetIncomeLoss`	$-10.41M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.82M	USD	Annual
Balance	`StockholdersEquity`	$7.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$314.45K	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.